Strs Ohio Grows Position in GE HealthCare Technologies Inc. $GEHC

Strs Ohio increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.8% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 385,940 shares of the company’s stock after purchasing an additional 14,231 shares during the quarter. Strs Ohio owned approximately 0.08% of GE HealthCare Technologies worth $28,587,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in GEHC. JPMorgan Chase & Co. lifted its stake in shares of GE HealthCare Technologies by 49.9% in the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after purchasing an additional 1,711,963 shares during the period. Nuveen LLC purchased a new position in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $77,058,000. Eminence Capital LP lifted its stake in shares of GE HealthCare Technologies by 38.7% in the 1st quarter. Eminence Capital LP now owns 1,819,129 shares of the company’s stock valued at $146,822,000 after purchasing an additional 507,101 shares during the period. Homestead Advisers Corp lifted its stake in shares of GE HealthCare Technologies by 92.7% in the 1st quarter. Homestead Advisers Corp now owns 988,600 shares of the company’s stock valued at $79,790,000 after purchasing an additional 475,500 shares during the period. Finally, Canada Pension Plan Investment Board lifted its stake in shares of GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after purchasing an additional 409,636 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 3.1%

GEHC stock opened at $75.00 on Friday. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The business has a fifty day moving average price of $75.10 and a 200-day moving average price of $72.91. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.93. The stock has a market capitalization of $34.24 billion, a P/E ratio of 15.50, a P/E/G ratio of 2.95 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same quarter in the previous year, the business earned $1.14 earnings per share. The company’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.87%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Morgan Stanley raised their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday. Wall Street Zen lowered GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Wells Fargo & Company lowered their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday. Finally, BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a research note on Wednesday. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.